Global Coronary Artery Disease Market Insights Forecasts to 2033

• The Global Coronary Artery Disease Market Size was Valued at USD 21.23 Billion in 2023
• The Market Size is Growing at a CAGR of 7.96% from 2023 to 2033
• The Worldwide Coronary Artery Disease Market Size is Expected to Reach USD 45.65 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period

The Global Coronary Artery Disease Market Size is Anticipated to Exceed USD 45.65 Billion by 2033, Growing at a CAGR of 7.96% from 2023 to 2033.

Market Overview

Coronary artery disease (CAD) is a condition characterized by the buildup of plaque (atherosclerosis) in the coronary arteries that is responsible for supplying oxygen-rich blood to the heart muscle. This plaque is mainly composed of cholesterol, fat, calcium, and other substances that accumulate on the artery walls, and restrict the blood flow. Reduced blood flow to the heart can cause chest pain (angina), shortness of breath, or other symptoms. If the blood flow becomes completely blocked, it can lead to a heart attack. CAD is a leading cause of death worldwide and is often associated with risk factors such as high blood pressure, increased cholesterol levels, smoking, diabetes, obesity, and a sedentary lifestyle. Early diagnosis and lifestyle changes, along with medications or surgical interventions like angioplasty or bypass surgery help to manage the condition and reduce the risk of serious complications. As per the data provided by the Centers for Disease Control and Prevention, Coronary heart disease (CAD) killed 371,506 people in 2022, with CAD affecting 5% of adults aged 20 and older, and 1 out of 5 deaths from CVD among younger adults.

Report Coverage

This research report categorizes the market for the global coronary artery disease market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global coronary artery disease market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global coronary artery disease market.

Driving Factors

Coronary artery disease (CAD) is a result of a combination of lifestyle, genetic, and environmental factors. Key risk factors include unhealthy diets, inactivity, smoking, high blood pressure, cholesterol, diabetes, obesity, excessive alcohol consumption, and chronic stress. Non-modifiable factors like age, gender, and family history of heart disease also contribute to CAD. Socioeconomic factors and limited healthcare access can delay diagnosis and treatment worsening the outcome. Addressing these factors through prevention, early detection, and lifestyle modifications can significantly reduce CAD incidence.

Restraining Factors

Advancements in medical technologies and increased awareness of preventive measures are key to reducing coronary artery disease (CAD). Public health initiatives, healthier lifestyles, better dietary choices, and physical activity also contribute to CAD reduction. Early diagnosis and increased availability of medications help manage risk factors like high cholesterol and hypertension.

Market Segmentation

The global coronary artery disease market share is classified into disease type, diagnosis, and treatment.

• The unstable angina segment is expected to hold the largest share of the global coronary artery disease market during the forecast period.   

Based on the disease type, the global coronary artery disease market is divided into stable angina, unstable angina, and myocardial infarction. Among these, the unstable angina segment is expected to hold the largest share of the global coronary artery disease market during the forecast period. The growth of the market for unstable angina is driven by increasing risk factors like hypertension, diabetes, and high cholesterol, as well as increased awareness of cardiovascular conditions. Early diagnosis and intervention are crucial for managing unstable angina, which can lead to a myocardial infarction. The geriatric population, advancements in diagnostic technologies, and improved treatment options are expected to accelerate demand for managing unstable angina. Healthcare systems will be better equipped to handle severe coronary artery conditions.

• The coronary angiography segment is expected to grow at the fastest CAGR in the global coronary artery disease market during the forecast period.   

Based on the diagnosis, the global coronary artery disease market is divided into electrocardiogram (ECG),    stress testing, coronary angiography, computed tomography (CT) scan, and magnetic resonance imaging (MRI). Among these, the coronary angiography segment is expected to grow at the fastest CAGR in the global coronary artery disease market during the forecast period. The growth of this segment is attributed to the adoption of minimally invasive diagnostic techniques, rising cases due to unhealthy lifestyles, and improved healthcare infrastructure. Coronary angiography is favored by healthcare professionals for diagnosing blockages in coronary arteries, particularly for severe cases. The demand for early and precise detection of coronary blockages, coupled with technological advancements in angiographic imaging, is expected to drive its expansion in the forecasted period.

• The percutaneous coronary intervention (PCI) segment is expected to grow at the fastest CAGR in the global coronary artery disease market during the forecast period.   

Based on the treatment, the global coronary artery disease market is divided into percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and lifestyle changes. Among these, the percutaneous coronary intervention (PCI) segment is expected to grow at the fastest CAGR in the global coronary artery disease market during the forecast period. PCI, or angioplasty, is a minimally invasive procedure used to treat coronary artery blockages. With the increasing prevalence of coronary artery disease and advancements in medical technology, PCI is preferred due to quicker recovery times and reduced risk compared to open-heart surgery. The availability of drug-eluting stents further boosts PCI adoption. The growth of PCI is expected to be driven by the demand for less invasive treatment methods and improvements in healthcare infrastructure.

Regional Segment Analysis of the Global Coronary Artery Disease Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global coronary artery disease market over the predicted timeframe.

North America is anticipated to hold the largest share of the global coronary artery disease market over the predicted timeframe. The region’s coronary artery disease (CAD) market is dominated by factors such as the high prevalence of CAD due to lifestyle factors, well-established healthcare infrastructure, and key market players. The region's access to advanced medical technologies and focus on early diagnosis and treatment further support its position. Increased healthcare expenditure and favorable reimbursement policies for CAD treatments are expected to contribute to the market's growth in this region.

Asia Pacific is expected to grow at the fastest pace in the global coronary artery disease market during the forecast period. The region is going to experience significant market growth due to its growing healthcare needs, largely due to factors such as the aging population, rapid urbanization, and economic development in countries like China and India. This has led to an increase in risk factors associated with cardiovascular diseases, such as diabetes and hypertension. Government initiatives to improve healthcare services and raise awareness about cardiovascular health are expected to further accelerate the adoption of CAD treatments.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global coronary artery disease market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories 
• Boston Scientific Corporation 
• Medtronic plc 
• Johnson & Johnson 
• Edwards Lifesciences Corporation 
• Siemens Healthineers 
• Philips Healthcare 
• Stryker Corporation 
• Terumo Corporation 
• Cardinal Health 
• Bayer AG 
• AstraZeneca 
• Sanofi 
• Gilead Sciences 
• Roche Diagnostics
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2024, Royal Philips introduced an AI-enabled cardiovascular ultrasound platform, aiming to expedite cardiac ultrasound analysis and alleviate the workload on echocardiography labs.

• In March 2024, Boston Scientific received FDA approval for the AGENT Drug-Coated Balloon, a treatment for coronary in-stent restenosis in patients with coronary artery disease.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global coronary artery disease market based on the below-mentioned segments: 

Global Coronary Artery Disease Market, By Disease Type

• Stable Angina
• Unstable Angina
• Myocardial Infarction

Global Coronary Artery Disease Market, By Diagnosis

• Electrocardiogram (ECG)
• Stress Testing
• Coronary Angiography
• Computed Tomography (CT) Scan
• Magnetic Resonance Imaging (MRI)

Global Coronary Artery Disease Market, By Treatment

• Percutaneous Coronary Intervention (PCI)
• Coronary Artery Bypass Grafting (CABG)
• Lifestyle Changes

Global Coronary Artery Disease Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa